Casdin Capital, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.24 Billion distributed in 37 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Revolution Medicines, Inc. with a value of $181M, Standard Biotools Inc. with a value of $168M, Biolife Solutions Inc with a value of $162M, Sarepta Therapeutics, Inc. with a value of $138M, and Relay Therapeutics, Inc. with a value of $61.6M.

Examining the 13F form we can see an increase of $284M in the current position value, from $955M to 1.24B.

Casdin Capital, LLC is based out at New York, NY

Below you can find more details about Casdin Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.24 Billion
Healthcare: $1.24 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 37
  • Current Value $1.24 Billion
  • Prior Value $955 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 3 stocks
  • Additional Purchases 13 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.